| Michelle Lynne Eichelberger, MSW | |
|
301 Palmetto Park Blvd, Lexington, SC 29072-7872 | |
| (803) 996-1500 | |
| Not Available |
| Full Name | Michelle Lynne Eichelberger |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 301 Palmetto Park Blvd, Lexington, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023177979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Lynne Eichelberger, MSW 301 Palmetto Park Blvd, Lexington, SC 29072-7872 Ph: (803) 996-1500 | Michelle Lynne Eichelberger, MSW 301 Palmetto Park Blvd, Lexington, SC 29072-7872 Ph: (803) 996-1500 |
News Archive
In 2007, a controversial pesticide was approved by the Food and Drug Administration for use on fruit and vegetable crops, mainly in California and Florida. Farm workers and scientists protested the approval of the pesticide because its active ingredient, methyl iodide, is a known carcinogen.
Researchers from the University of British Columbia have discovered that the betacoronavirus-encoded papain-like protease disrupts autophagy, partly by targeting ULK1. Their work is reported on the preprint server bioRxiv* in October 2020.
Patient satisfaction with their medications and the quality of interactions with their doctor reflect the success of gastroesophageal reflux disease (GERD) therapy, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
The Obama administration granted another 106 waivers last month from part of the health care reform law -; the first round of three-year waivers the Health and Human Services Department has approved. The new approvals bring the total number of waivers to 1,472, according to HHS. Those figures cover waivers granted through the end of July.
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.
› Verified 5 days ago
Hannah Latta, M.A., LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 415 Barr Rd, Lexington, SC 29072 Phone: 803-546-8228 | |
Miss Bodequia Simon, LMSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 108 Palmetto Park Blvd Ste D, Lexington, SC 29072 Phone: 803-996-1500 | |
Hugh A. Henderson, CAC, CPE, MDN Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Palmetto Park Blvd, Lexington, SC 29072 Phone: 803-996-1500 | |
Ms. Freddie Karen Busha, LPC/S Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Palmetto Park Blvd, Lexington, SC 29072 Phone: 803-996-1500 | |
Mrs. Mary Ellen Grigsby, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 426 S Lake Dr, Lexington, SC 29072 Phone: 803-814-5559 | |
Amy N. Mills, MSW, LMSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Palmetto Park Blvd, Lexington, SC 29072 Phone: 803-996-1500 |